Hester Pharmaceuticals Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hester Pharmaceuticals Limited with three other
pharmaceutical manufacturers in Asia:
Mycenax Biotech Incorporated
sales of 200.61 million Taiwanese Dollars [US$6.58 million]
of which 100%
was Biological Medicine),
Ina Research Incorporation
(2.12 billion Japanese Yen [US$19.05 million]
of which 80%
was Non-clinical business), and
based in Japan
(2.47 billion Japanese Yen [US$22.27 million]
of which 64%
was Health Inspection Equipment).
During the year ended March of 2016, sales at
Hester Pharmaceuticals Limited were 1.01 billion Indian Rupees (US$15.42 million).
increase of 11.3%
versus 2015, when the company's sales were 906.35 million Indian Rupees.
This was the fifth consecutive year of sales increases at Hester Pharmaceuticals Limited
(and since 2011, sales have increased a total of 141%).
Sales of Large Animal Health Production saw an increase
that was more than double the company's growth rate: sales were up
73.2% in 2016, from
54.23 million Indian Rupees to 93.94 million Indian Rupees.